AstraZeneca PLC Submits sNDA for SEROQUEL XR(TM) for the Treatment …

Antidepressants increased the risk of suicidal thinking and behavior in children, adolescents, and young adults in short-term studies of major depressive disorder and other psychiatric disorders . … (1,2) The disorder comes on gradually and can begin across the life cycle. GAD rarely occurs alone and is often accompanied by other anxiety disorders , depression , or substance abuse. Genetic factors are also thought to be involved

View original post here: 
AstraZeneca PLC Submits sNDA for SEROQUEL XR(TM) for the Treatment …

Popularity: unranked [?]

Technorati Tags: , , , , , , , , , , , , ,

No Comments

Leave a reply

You must be logged in to post a comment.

Powered by Yahoo! Answers